241 - Peritoneal Dialysis: Assessment and Management for Increased Longevity

Description

This session focuses on assessing and managing the peritoneal dialysis patient across the lifespan and disease continuum. Special considerations for patients with diabetes, decreased residual renal function, and obesity as well as potential infectious and noninfectious complications are discussed.

Continuing Education Instructions and Disclosure Information

Contact hours available until 4/17/2021.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: Elizabeth St. John – Employee, Fresenius Kidney Care

Speaker Disclosure: Rhonda Duggan – Employee, Fresenius Medical Care Renal Therapies Group; Speaker, Alexion Pharmaceuticals

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Learning Outcome:
Nephrology nurses will outline the appropriate assessments and management of patients on peritoneal dialysis with a goal of preserving the peritoneal membrane as long as possible.

Speaker(s):

• Rhonda Duggan, MSN RN CTC